Table 4.
Summary of treatment-related adverse events.
| Event | N = 12 | Percentage (%) |
|---|---|---|
| Any adverse event | ||
| Anemia | 9 | 75.0 |
| White blood cell count decreased | 8 | 66.7 |
| Neutrophil count decreased | 8 | 66.7 |
| Platelet count decreased | 6 | 50.0 |
| Hand–foot syndrome | 3 | 25.0 |
| Asthenia | 2 | 16.7 |
| Astriction | 2 | 16.7 |
| Hypertension | 2 | 16.7 |
| Protein urine | 2 | 16.7 |
| Aspartate aminotransferase increased | 2 | 16.7 |
| Blood creatinine increased | 1 | 8.3 |
| Nausea | 1 | 8.3 |
| CTC (common terminology criteria) grade 3 or higher adverse events | ||
| Neutrophil count decreased | 6 | 50.0 |
| White blood cell count decreased | 4 | 33.3 |
| Platelet count decreased | 1 | 8.3 |
| Protein urine | 1 | 8.3 |